Chitinase-3-like protein 1 (CH3L1) and Neurosecretory protein VGF (VGF) as two novel CSF biomarker candidates for improved diagnostics in Alzheimer’s disease
Payam Emami Khoonsari(Stockholm University), Kim Kultima(Uppsala University), Julia Remnestål(Science for Life Laboratory), Lars Lannfelt(BioArctic Neuroscience (Sweden)), Ganna Shevchenko(Uppsala University), Peter Nilsson, Henrik Zetterberg(University of Wisconsin–Madison), Stephanie Herman(Uppsala University), Lena Kilander(British Geriatrics Society), Malin Degerman Gunnarsson(Uppsala University), Martin Ingelsson(Uppsala University), RoseMarie Brundin(Uppsala University), Sravani Musunuri(Uppsala University)
Unknown
January 1, 2017
Cited by 1
Related Papers
Defeating Alzheimer's disease and other dementias: a priority for European science and society
|The Lancet Neurology|2016|1.7k
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody
|Alzheimer s Research & Therapy|2021|818